4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin.
The efficacy and safety of a 4-week course of intravenous teicoplanin (500 mg every 12 h for the first 2 days and 10 mg/kg of body weight every 24 h thereafter) in the treatment of streptococcal native valve endocarditis in 20 patients were evaluated. All blood isolates were inhibited by a concentra...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1992
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189370/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1386972/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.723 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|